The objectives of this study were to (1)
determine the level of the molecule IPG- P type at clinical diagnosis of preeclampsia.
(2) predict the occurrence of preeclampsia 1 week, 2 weeks and 4 weeks before clinical diagnosis of PE.
(3) determine sensitivity, specificity, positive and negative likelihood ratios of the IPG-P test in preeclampsia